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Introduction 
Despite the fact that some states have legalized medical marijuana, 
disabled employees are being fired for using it. Gary Ross, disabled from 
injuries suffered while he served in the United States Air Force, began 
using medical marijuana after traditional medications failed to alleviate 
his pain.1 Joseph Casias used medical marijuana to alleviate pain caused 
by sinus cancer and an inoperable brain tumor.2 Brandon Coats, a quad-
riplegic, used medical marijuana to control painful muscle spasms 
 
1. Ross v. RagingWire Telecomms., Inc., 174 P.3d 200, 203 (Cal. 2008). 
2. Casias v. Wal-Mart Stores, Inc., 695 F.3d 428, 431 (6th Cir. 2012). 
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caused by his paralysis.3 All of these employees were fired when their 
employers found out that they used marijuana.4 
How can someone be fired for using a drug that is authorized by 
state law? Normally, the federal Americans with Disabilities Act (ADA) 
would protect disabled persons that use legally prescribed drugs from 
employment discrimination that stems from that drug use. But the 
ADA does not protect users of illegal drugs, and marijuana is illegal 
under federal law. 5 Thus, the ADA does not protect disabled medical 
marijuana users when they are fired for violating workplace drug testing 
policies. 
Medical marijuana users have tried suing their employers under the 
theory that state medical marijuana laws protect employees from the 
consequences of violating drug-free workplace policies.6 But, in the 
absence of explicit statutory language granting employment protection 
to medical marijuana users, the courts refuse to rule in favor of the 
employees. Court decisions favoring employers place a substantial 
burden on medical marijuana patients—choosing between “giving up 
what may be their only source of income, or . . . discontinu[ing] mari-
juana treatment, and try[ing] to endure their chronic pain or other 
condition for which marijuana may provide the only relief.”7 A clearly 
drafted statutory provision that prevents employers from using medical 
marijuana users’ drug use as a reason to terminate them will alleviate 
the burden that employees currently bear. 
Part I of this Note gives a brief history of marijuana regulation in 
the United States. Part II describes how drug testing works and why 
employers do it. And it presents some of the issues that the federal 
prohibition poses for employers and employees. Part III analyzes state 
court opinions that have addressed the question of whether employers 
may fire employees for off-site medical marijuana use that does not  
3. Opening Brief at 18, Coats v. Dish Network, LLC, 350 P.3d 849 (Colo. 2015), 
(No. 2013SC000394). 
4. Ross, 174 P.3d at 203; Casias, 695 F.3d at 432; Coats v. Dish Network, 
LLC, 303 P.3d 147, 149 (Colo. App. 2013), aff’d, 350 P.3d 849 (Colo. 2015).  
5. See 42 U.S.C. § 12210(a) (2012) (“For purposes of this chapter, the term 
‘individual with a disability’ does not include an individual who is 
currently engaging in the illegal use of drugs, when the covered entity acts 
on the basis of such use.”); 42 U.S.C. § 12111(6) (2012) (defining “illegal 
use of drugs” as a use of a Schedule I-V controlled substance unless the 
substance is “taken under supervision by a licensed health care profess-
ional” or otherwise authorized by federal law); see also Russell Rendall, 
Medical Marijuana and the ADA: Removing Barriers to Employment for 
Disabled Individuals, 22 Health Matrix 315, 324–325  (2012) (describing 
two federal court decisions that held that medical marijuana is illegal for 
the purposes of the ADA). 
6. See, e.g., Ross, 174 P.3d at 204; Casias, 695 F.3d at 432. 
7. Ross, 174 P.3d at 211 (Kennard, J., concurring and dissenting). 
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impair work performance. Every court thus far has ruled in favor of the 
employer, but some of the opinions and dissents acknowledge that the 
legislatures could amend their states’ statutes to include employment 
protections for medical marijuana users. Part IV analyzes the strengths 
and weaknesses of the state medical marijuana laws that include some 
form of employment protection. Finally, Part V proposes statutory 
language that could be included in state medical marijuana laws to 
protect employees from termination simply because of their authorized 
use of marijuana. 
I. Marijuana Regulation Since the 1970s 
Marijuana is illegal under federal law.8 But its legal status in the 
states is rapidly changing. Twenty-three states, as well as the District 
of Columbia, currently allow medical marijuana.9 Four states and D.C. 
also allow marijuana for recreational use.10 The change in state laws 
reflects the public’s changing opinion on marijuana.11 Federal law, 
however, remains unchanged. The federal Controlled Substances Act 
(CSA) classifies marijuana as a Schedule I substance, meaning that 
marijuana has no medicinal value and high potential for abuse.12 
Because the drafters of the CSA had limited knowledge of 
marijuana, they created the National Commission on Marihuana and 
Drug Abuse (Commission) to study marijuana and submit a report to 
Congress with its findings and recommendations.13 Congress mandated 
that the Commission research (1) the prevalence of marijuana use in 
the United States, (2) “the efficacy of existing marihuana laws,” (3) the 
physiological and psychological long-term effects of marijuana, (4) the 
 
8. 21 U.S.C. §§ 812(c)(c)(10), 841(a) (2012). 
9. The states are Alaska, Arizona, California, Colorado, Connecticut, 
Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, 
Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, 
New York, Oregon, Rhode Island, Vermont, and Washington. State 
Medical Marijuana Laws, Nat’l Conference of State Legislatures  
(Sept. 14, 2015), http://www.ncsl.org/research/health/state-medical- 
marijuana-laws.aspx [https://perma.cc/2AMD-9U6A]. 
10. The states are Alaska, Colorado, Oregon, and Washington. Id. 
11. A Pew Research Center survey conducted October 15–20, 2014, reported 
that 52% of Americans support legalizing marijuana and only 45% oppose. 
Slim Majority Supports Marijuana Legalization, Pew Research Ctr.  
(Oct. 23, 2014), http://www.people-press.org/2014/10/23/as-midterms- 
near-gop-leads-on-key-issues-democrats-have-a-more-positive-image/slim- 
majority-supports-marijuana-legalization/ [https://perma.cc/R9ZK-S4BE]. 
12. 21 U.S.C. § 812(b)(1)(A)–(B) (2012). 
13. Establishment of Commission on Marihuana and Drug Abuse, Pub. L. 
No. 91-513, § 601(e), 84 Stat. 1280, 1281 (1970). 
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relationship between marijuana use and aggression and crime, (5) “the 
relationship between marihuana and the use of other drugs,” and (6) 
“the international control of marihuana.”14 
The Commission released its report, Marihuana: A Signal of 
Misunderstanding (Report), in 1972.15 After conducting over fifty 
projects,16 the Commission rejected the federal government’s total 
prohibition policy on marijuana.17 The Report stated that “[t]his policy 
grew out of a distorted and greatly exaggerated concept of the drug’s 
ordinary effects upon the individual and the society.”18 The Report 
recommended instead a policy of decriminalization pending more 
research on marijuana.19 Congress did not listen to the Commission’s 
recommendations and has kept marijuana as a Schedule I substance. 
Despite the Commission’s recommendation to continue researching 
marijuana, those who wish to do so face significant obstacles in the 
United States.20 The only federally legal source for researchers to obtain 
marijuana is a twelve-acre plot at the University of Mississippi, 
controlled by the National Institute on Drug Abuse.21 To access this 
marijuana, researchers must gain approval from a number of federal 
administrative agencies.22 Between 1999 and June 2015, only sixteen in-
dependently funded studies obtained marijuana through this process.23 
 
14. Id. § 601(d)(1)(A)–(F), 84 Stat. at 1281. 
15. Nat’l Comm’n on Marihuana and Drug Abuse, Marihuana: A 
Signal of Misunderstanding (1972) [hereinafter Report]. 
16. Id. at 2. 
17. Id. at 175. 
18. Id. at 162. 
19. Id. at 189. See also Gerald F. Uelmen & Alex Kreit, Drug Abuse 
and the Law Sourcebook § 3:73, Westlaw (database updated Nov. 
2014) (explaining that the Commission “unanimously recommended a 
social policy of marijuana discouragement: specifically not legalization, as 
with the alcohol or tobacco models, but also no imprisonment for 
possession of marijuana for personal use (i.e., ‘decriminalization’)”). 
20. Report, supra note 15, at 219; Uelmen & Kreit, supra note 19, at § 1:27. 
21. Id. See also David Kelly, Colorado Seeks Permission to Grow Pot at 
State Universities, L.A. Times, Jan. 25, 2015, http://www.latimes.com/nation/ 
la-na-pot-research-20150125-story.html [https://perma.cc/P5Y2-FTUF]. 
22. FDA and Marijuana, Food and Drug Admin., http://www.fda.gov/ 
NewsEvents/PublicHealthFocus/ucm421163.htm [http://perma.cc/VB54-
CSMD] (last updated Mar. 3, 2015). 
23. Independently Funded Studies Receiving Research Grade Marijuana, Nat’l 
Inst. on Drug Abuse, http://www.drugabuse.gov/drugs-abuse/marijuana/ 
independently-funded-studies-receving-research-grade-marijuana-1999-
to-present [http://perma.cc/6327-2UZ8] (last updated July 2015). 
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This process is “complicated” and does not fulfill the demand for 
medical marijuana research.24 
Along with research from other countries and analysis of self-
reported data, the results of the FDA-approved clinical marijuana 
studies, suggest that marijuana does have a medicinal value, despite its 
Schedule I classification. The research suggests that marijuana can 
benefit persons suffering from a myriad of conditions, including chronic 
pain,25 epilepsy,26 spasticity,27 and cancer.28 While the growing body of 
research on marijuana’s beneficial therapeutic uses has not swayed the 
FDA or DEA to reschedule marijuana, it has swayed voters and 
 
24. A policy paper released by the American College of Physicians states that 
“[u]nfortunately, research expansion has been hindered by a complicated 
federal approval process, limited availability of research-grade marijuana, 
and the debate over legalization.” Tia Taylor, Am. Coll. of 
Physicians, Supporting Research Into the Therapeutic Role of 
Marijuana 1 (2008). Similarly, the American Medical Association’s 
policy statement on medical marijuana encourages further research on 
marijuana’s therapeutic effects. H-95.952 Cannabis for Medicinal Use, 
Am. Med. Ass’n, https://www.ama-assn.org/ssl3/ecomm/PolicyFinder
Form.pl?site=www.ama-assn.org&uri=/resources/html/PolicyFinder/ 
policyfiles/HnE/H-95.952.HTM [https://perma.cc/3RQS-K6VT]  
(last visited Sept. 28, 2015). 
25. See Mary E. Lynch & Fiona Campbell, Cannabinoids for Treatment of 
Chronic Non-Cancer Pain; A Systematic Review of Randomized Trials, 
72 Brit. J. Clinical Pharmacology 735, 742 (2011) (conducting a 
review of eighteen randomized control trials that tested the efficacy of 
marijuana as treatment for chronic pain and finding that marijuana is a 
“modestly effective and safe treatment option for chronic non-cancer 
(predominantly neuropathic) pain”). 
26. See Brenda E. Porter & Catherine Jacobson, Report of a Parent Survey 
of Cannabidiol-Enriched Cannabis Use in Pediatric Treatment-Resistant 
Epilepsy, 29 Epilepsy & Behav. 574, 575 (2013) (finding that parents 
that treat their children’s epilepsy with certain strains of marijuana report 
a “high rate of success in reducing seizure frequency with this treatment”); 
Jack Healy, Families See Colorado as New Frontier on Medical  
Marijuana, N.Y. Times, Dec. 5. 2013, http://www.nytimes.com/2013/ 
12/06/us/families-see-colorado-as-new-frontier-on-medical-marijuana. 
html?_r=0 [https://perma.cc/ZCW8-P5J9] (describing how families are 
moving to Colorado to treat their children’s seizures with marijuana). 
27. See Jody Corey-Bloom et al., Smoked Cannabis for Spasticity in Multiple 
Sclerosis: A Randomized, Placebo-Controlled Trial, 184 Canadian Med. 
Ass’n J. 1143, 1145 (2012) (administering marijuana to patients with multiple 
sclerosis and spasticity resulted in a “clinically meaningful” reduction in pain). 
28. Clinical (human) trials on marijuana and cancer show that marijuana can help 
with nausea, appetite stimulation, pain relief, anxiety, and sleep. See Cannabis 
and Cannabinoids, Nat’l Cancer Inst. http://www.cancer.gov/about-
cancer/treatment/cam/patient/cannabis-pdq#section/all [https://perma.cc/ 
P2GN-B45W] (last updated July 16, 2015). Pre-clinical (laboratory or animal) 
studies show that marijuana might also promote antitumor activity. Id. 
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legislators in twenty-three states to make marijuana available for 
medical use.29 
Federal enforcement of the CSA in the twenty-three states that 
have legalized medical marijuana is weak. In 2009 Deputy Attorney 
General David Ogden released a memo addressed to federal prosecutors 
saying that prosecution of seriously ill individuals using marijuana in 
compliance with state law was an inefficient use of federal resources.30 
Deputy Attorney James Cole reaffirmed the Ogden Memo in 2011. 31 In 
2013, Cole issued another memo offering more guidance to federal pro-
secutors on how to treat state law–compliant medical marijuana users.32 
In the Memo, Cole outlined the following eight enforcement priorities: 
(1) keeping marijuana away from minors, (2) preventing criminal enter-
prises from profiting from medical marijuana, (3) restricting marijuana 
diversion from one state to another, (4) ensuring that legal marijuana 
activity is not a pretext for illegal activity, (5) preventing violence and 
gun activity in marijuana growing, (6) preventing drugged driving and 
other adverse public health consequences, (7) protecting federal land, 
and (8) keeping marijuana off of federal property.33 Outside of these 
eight priorities, the Department of Justice “has traditionally relied on 
states and local law enforcement agencies to address marijuana activity 
through enforcement of their own narcotics laws.”34 
In December 2014, Congress passed an omnibus spending bill that 
prohibited use of federal funds to interfere with state medical marijuana 
laws.35 That meant that for the 2015 fiscal year the Department of  
29.  State Medical Marijuana Laws, Nat’l Conference of State 
Legislatures (Sept. 14, 2015), http://www.ncsl.org/research/health/ 
state-medical-marijuana-laws.aspx [https://perma.cc/2AMD-9U6A]. 
30. Memorandum from David W. Ogden, Deputy Att’y Gen., to Selected United 
States Att’ys, Investigations and Prosecutions in States Authorizing the 
Medical Use of Marijuana (Oct. 19, 2009), http://www.justice.gov/sites/ 
default/files/opa/legacy/2009/10/19/medical-marijuana.pdf [http://perma. 
cc/67YQ-LWZG] [hereinafter Ogden Memo]. 
31. Memorandum from James M. Cole, Deputy Att’y Gen., to United States 
Att’ys, Guidance Regarding the Odgen Memo in Jurisdictions Seeking to 
Authorize Marijuana for Medical Use, (June 29, 2011), http://www.justice. 
gov/sites/default/files/oip/legacy/2014/07/23/dag-guidance-2011-for-
medical-marijuana-use.pdf [http://perma.cc/PKN9-DYCS] [hereinafter 
Cole Memo 2011]. 
32. Memorandum from James M. Cole, Deputy Att’y Gen., to United States 
Att’ys, Guidance Regarding Marijuana Enforcement, (Aug. 29, 2013),  
http://www.justice.gov/iso/opa/resources/3052013829132756857467.pdf  
[http://perma.cc/NBT6-CC85] [hereinafter Cole Memo 2013]. 
33. Id. 
34. Id. 
35. Consolidated and Further Continuing Appropriations Act, 2015, Pub. L. 
No. 113-235, § 538, 128 Stat. 2130, 2217 (2014).  
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Justice will be unable to use any funds to prevent states “from 
implementing their own State laws that authorize the use, distribution, 
possession, or cultivation of medical marijuana.”36 This, in addition to 
the Ogden and Cole memos, sends the message that Congress does not 
think that the CSA should be enforced against medical marijuana users. 
While the current federal policy towards medical marijuana is non-
enforcement, marijuana remains illegal under the CSA. Enforcement 
policies are subject to change with administrations, so, until the CSA 
is amended, the federal government will retain the power to prosecute 
violations of the CSA. As long as marijuana remains on Schedule I, 
employers can argue that their drug-free workplace policies, likely 
containing blanket prohibitions on illegal drugs, apply to medical mari-
juana users. 
II. Workplace Drug Testing 
Despite the quasi-legal status of marijuana, employers can still fire 
medical marijuana users for positive drug tests. One of the strongest 
criticisms against drug testing raised by medical marijuana users is that 
urine tests, the most common form of drug tests, are not an indication 
of marijuana impairment.37 A few hours after marijuana is ingested, 
marijuana’s primary psychoactive ingredient, delta-9-tetrahydro-
cannabinol (THC),38 metabolizes into a non-psychoactive metabolite, 
THC-COOH.39 Although the effects of the THC only last a few hours, 
detectable levels of THC-COOH can remain in a marijuana user’s 
system for over a month.40 This means that medical marijuana users 
can fail drug tests even if they use marijuana off-site and the THC is 
not active in their systems at work.41 
The statute presented in this Note is not meant to prevent 
employers from conducting drug tests of employees. Rather, its goal is 
to protect employees from being punished for using a drug that may be 
the best form of relief available for their conditions. The fact that drug  
36. Id. 
37. See Stacy A. Hickox, Drug Testing of Medical Marijuana Users in the 
Workplace: An Inaccurate Test of Impairment, 29 Hofstra Lab. & Emp. 
L.J. 273, 299 (2012). 
38. See Robert S. Goodwin et al., Urinary Elimination of 11-Nor-9-Carboxy-Δ9-
tetrahydrocannabinol in Cannabis Users During Continuously Monitored 
Abstinence, 32 J. Analytical Toxicology 562, 562 (2008). 
39. People v. Feezel, 783 N.W.2d 67, 83 (Mich. 2010) (“[THC-COOH] is a 
metabolite—a natural byproduct that is created when a person’s body 
breaks down THC.”). 
40. See, e.g., Goodwin, supra note 38, at 567; Hickox, supra note 37, at 288. 
41. See Stacy A. Hickox, Clearing the Smoke on Medical Marijuana Users in 
the Workplace, 29 Quinnipiac L. Rev. 1001, 1009 (2011). 
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tests are a poor indicator of marijuana impairment strengthens the 
argument that employers should not use positive drug tests to discrim-
inate against medical marijuana users. Medical marijuana users require 
protection because “[t]he imbalance of economic power gives employers 
the ability to control more than is rightfully theirs.”42 The statute in 
this Note attempts to correct that imbalance. Writing a fair statute, 
however, requires an understanding of employers’ reasons for drug 
testing employees. This section discusses employers’ reasons for drug 
testing and explains how the proposed statute addresses those reasons. 
Compliance with state and federal law is one reason that employers 
drug test. For example, the federal Drug Free Workplace Act (DFWA) 
imposes certain conditions on the receipt of federal contracts worth 
more than $100,000 or federal grants of any value.43 Recipients must 
promote a drug-free workplace, which includes informing employees 
that use of controlled substances, even if legal under state law, will 
result in actions taken against the employee.44 If an employer fails to 
impose sanctions on employees that use controlled substances illicitly, 
or if an employer fails to take any of the other required statutory 
measures to promote a drug-free workplace, it can lose its federal grant 
or contract.45 The DFWA does not explicitly require drug testing. 
Nevertheless, an employer could not knowingly employ a medical 
marijuana user under the DFWA because employees are prohibited 
from “engaging in the unlawful . . . use of a controlled substance,” and 
marijuana is an unlawful controlled substance.46 
Employers of commercial motor vehicle operators must also drug 
test employees to screen for controlled substances and alcohol.47 The 
tests must be conducted before employment, at random, under reason-
able suspicion, and after accidents.48 The Department of Transportation 
does not make an exception to this policy for medical marijuana users.49 
Similarly, the Federal Railroad Administration requires employers to 
 
42. Lewis L. Maltby & Bernard J. Dushman, Whose Life Is It Anyway—
Employer Control of Off-Duty Behavior, 13 St. Louis U. Pub. L. Rev. 645, 
659 (1994). 
43. 41 U.S.C. §§ 8102(a)(1), 8103(a)(1) (2012). 
44. 41 U.S.C. §§ 8102–8103 (2012). 
45. Id. 
46. 41 U.S.C. § 8101(a)(5)(B) (2012). 
47. 49 U.S.C. § 31306(b) (2012). 
48. Id. 
49. See DOT ‘Medical’ Marijuana Notice, U.S. Dep’t of Transp. (Feb. 13, 
2015), http://www.transportation.gov/odapc/medical-marijuana-notice 
[https://perma.cc/K38N-83XW]. 
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drug test train and signal employees.50 Schedule I substances are 
completely prohibited.51 Schedule II-V substances may be used if the 
employee’s treating physician prescribed them at an authorized level 
“consistent with the safe performance of the employee’s duties.”52 The 
physician must be informed of certain relevant information, such as the 
employee’s medical history, work duties, and other treating sources.53 
The employee must use the prescription in accordance with the dosage 
prescribed.54 
Some state laws also require drug testing as a condition of 
employment for certain employees, such as school bus drivers55 and 
state contractors.56 Other state laws incentivize employers to drug test 
employees by offering benefits to those that implement drug-free work-
place policies. For example, Ohio offers workers’ compensation premium 
rebates to employers that comply with the state’s drug-free safety 
program, which requires drug testing employees.57 
Even when the law does not require employers to drug test 
employees, some choose to do so anyway. Some legal scholars have 
noted that employers are concerned about the effect marijuana use has 
on workplace safety, employee performance, and absenteeism.58 Quest 
Diagnostics, a major drug testing provider to the government and 
private sector, conducted approximately 6.6 million urine drug tests for 
 
50. 49 C.F.R. § 219.601 (2014). 
51. 49 C.F.R. § 219.102 (2014) (“No employee who performs covered service 
may use a controlled substance at any time, whether on duty or off duty, 
except as permitted by § 219.103.”). 
52. 49 C.F.R. § 219.103 (2014). 
53. 49 C.F.R. § 219.103(a)(1), (3) (2014). 
54. 49 C.F.R. § 219.103(a)(2) (2014). 
55. See Alaska Stat. § 14.09.025 (2014) (requiring random drug testing of 
school bus drivers); Ariz. Rev. Stat. Ann. § 15-513 (2014) (requiring 
drug testing of school transportation authorities if there is “probable cause 
that the employee’s job performance has been impaired by the use of 
alcohol or a drug”). 
56. See La. Rev. Stat. Ann. § 49:1021(B) (Supp. 2015) (requiring the 
commissioner of administration to “establish and administer a program 
for random drug testing for all persons who receive anything of economic 
value or receive funding from the state”). 
57. Ohio Admin. Code 4123-17-58 (Supp. 2014). 
58. See James M. Shore, Medical Marijuana and Zero Tolerance Drug Testing 
Policies, Emp. Benefit Plan Rev., May 2011, at 6, 7; Deborah J. La Fetra, 
Medical Marijuana and the Limits of the Compassionate Use Act: Ross v. 
RagingWire Telecommunications, 12 Chap. L. Rev. 71, 73–74 (2008). 
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employers in 2014.59 The fact that one company has conducted so many 
tests indicates that drug testing is a prevalent employment issue. 
The statutory language presented in this Note prohibits an 
employer from discriminating against a medical marijuana user based 
on a positive drug test, but exempts employers that are subject to the 
DFWA or mandatory drug testing laws. This protects employers 
seeking to comply with the law. The statute in this Note also exempts 
medical marijuana users from protection if their marijuana use poses a 
threat of harm to the workplace or interferes with their ability to 
perform essential job duties. This protects employers seeking to dis-
cipline employees for poor performance. Both of these exemptions 
alleviate the concerns that employers have about employing marijuana 
users. Employers can still maintain their drug-free workplace policies 
for recreational marijuana users and users of other illicit drugs. Medical 
marijuana users are protected because employers cannot use positive 
drug tests, which do not even indicate impairment, as evidence that the 
users cannot adequately perform their jobs. 
III. Court Responses to Conflicting Federal and  
State Marijuana Laws 
Some medical marijuana users have sought relief from the courts 
after being fired for positive drug tests. The courts’ responses have 
largely denied such relief. In every case, the employee (or prospective 
employee) used medical marijuana off-site and was not impaired at 
work. Nevertheless, in every case the courts upheld the employers’ right 
to terminate their employees for marijuana use. The courts have ruled 
in favor of the employers for two general reasons: (1) federal law 
preempted any state law purporting to legalize marijuana use60 or (2) 
the state medical marijuana statute did not address employment, and 
thus did not remove an employer’s power to fire employees for using 
marijuana.61 
 
59. Illicit Drug Positivity Rate Increases Sharply in Workplace Testing, Finds 
Quest Diagnostics Drug Testing Index Analysis, Quest Diagnostics  
(June 9, 2015), http://www.questdiagnostics.com/home/physicians/health- 
trends/drug-testing.html [https://perma.cc/L3XP-BGWQ]. For an archived 
list of Quest’s drug testing reports, see Drug Testing Index Archives,  
Quest Diagnostics, http://www.questdiagnostics.com/home/physicians/ 
health-trends/drug-testing/archives.html [https://perma.cc/9ERP-PSJD] 
(last visited Sept. 29, 2015). 
60. See Emerald Steel Fabricators, Inc. v. Bureau of Labor & Indus., 230 P.3d 
518, 536 (Or. 2010). 
61. See, e.g., Roe v. Teletech Customer Care Mgmt. LLC, 257 P.3d 586, 590 
(Wash. 2011); Ross v. RagingWire Telecomms., Inc., 174 P.3d 200 (Cal. 2008). 
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A. The Risk of Federal Preemption 
If state medical marijuana laws are preempted by the CSA, then 
they cannot protect medical marijuana users because they will be 
“without effect.”62 In the CSA, Congress expressly stated that it did not 
intend to “occupy the field in which [the CSA] operates.” 63 This means 
that states may create their own drug laws. If, however, there is a 
“positive conflict” between the CSA and state law “so that the two 
cannot consistently stand together,” then the CSA will preempt the 
state law.64 Conflict preemption exists in two situations: (1) when it is 
physically impossible to comply with both federal and state law and (2) 
when state law “stands as an obstacle” to Congress’s purpose.65 
1. State Courts Have Come to Different Decisions about Whether 
Federal Law Preempts State Medical Marijuana Laws 
While courts agree that medical marijuana laws do not make 
compliance with the CSA impossible,66 they have come to differing con-
clusions about whether medical marijuana laws are an obstacle to the 
accomplishment of the CSA’s purpose.67 To analyze this issue courts 
use “two cornerstones of . . . pre-emption jurisprudence.”68 First is Con-
gressional purpose.69 The CSA’s two main purposes, as identified by the 
Supreme Court, are combatting drug abuse and controlling drug traffic-
 
62. Maryland v. Louisiana, 451 U.S. 725, 746 (1981) (“The Supremacy Clause 
provides that ‘[t]his Constitution, and the Laws of the United States which 
shall be made in Pursuance thereof . . . shall be the supreme Law of the 
Land . . . any Thing in the Constitution or Laws of any State to the Contrary 
notwithstanding.’ It is basic to this constitutional command that all 
conflicting state provisions be without effect.”) (internal citation omitted). 
63. 21 U.S.C. § 903 (2012). 
64. Id. 
65. See, e.g., Emerald Steel, 230 P.3d at 528 (quoting Freightliner Corp. v. 
Myrick, 514 U.S. 280, 287 (1995)); Arizona v. United States, 132 S. Ct. 2492, 
2501 (2012). 
66. Medical marijuana laws only authorize marijuana use, they do not require 
it. It is not impossible to comply with federal law and medical marijuana 
laws because a person can choose to refrain from marijuana use. See, e.g., 
Emerald Steel, 230 P.3d at 528. 
67. Compare Emerald Steel, 230 P.3d 518 (holding that the Oregon Medical 
Marijuana Act did not fail under an impossibility preemption analysis but 
did fail under an obstacle preemption analysis), with White Mountain 
Health Ctr. Inc. v. Cnty. of Maricopa, No. CV 2012-053585, 2012 WL 
6656902 (Ariz. Sup. Ct. Dec. 3 2012) (holding that Arizona’s medical 
marijuana act was not preempted by the CSA). 
68. Wyeth v. Levine, 555 U.S. 555, 565 (2009). 
69. Id. 
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king.70 The second cornerstone is “the assumption that the historic 
police powers of the States were not to be superseded by the Federal 
Act unless that was the clear and manifest purpose of Congress.”71 Drug 
policy has traditionally been a police power of the state,72 so medical 
marijuana laws should be granted the presumption of validity.73 
In Emerald Steel v. Bureau of Labor and Industries,74 the Oregon 
Supreme Court held that the CSA intended to accomplish its objectives 
through a blanket prohibition on marijuana.75 It does not matter if a 
person purports to be using marijuana for medical purposes because 
“by classifying marijuana as a Schedule I drug, Congress has expressed 
its judgment that marijuana has no recognized medical use.”76 Thus, a 
state law that authorizes marijuana use, for any reason, is an obstacle 
to Congress achieving its goals in implementing the CSA.77 The dissent 
did not think that Oregon’s medical marijuana law would contravene 
the purpose of the CSA, especially in light of the federal government’s 
pronouncement in the Ogden memo.78 The Ogden memo stated that the 
federal government would “not enforce the [CSA] against ‘individuals 
whose actions are in clear and unambiguous compliance with existing 
state laws permitting the medical use of marijuana.’”79 Therefore, the 
dissent argued, it is not the “clear and manifest purpose of Congress”80 
to preempt state medical marijuana laws.81  
70. Gonzales v. Raich, 545 U.S. 1, 12 (2005); see also Todd Garvey & Brian 
T. Yeh, Cong. Research Serv., R43034, State Legalization of 
Recreational Marijuana: Selected Legal Issues 11 (2014) (noting 
that the Supreme Court discussed the CSA’s purpose in Gonzales).  
71. Wyeth, 555 U.S. at 565 (quoting Medtronic, Inc. v. Lohr, 518 U.S. 470, 
485 (1996)). 
72. Cole Memo 2013, supra note 32 (“[T]he federal government has 
traditionally relied on states and local law enforcement agencies to address 
marijuana activity through enforcement of their own narcotics laws.”). 
73. See Garvey & Yeh, supra note 70 at 11-12. 
74.  230 P.3d 518 (Or. 2010). 
75. Id. at 529. 
76. Id. 
77. Id. 
78. Id. at 543 (Walters, J., dissenting) (citing Memorandum from David W. 
Ogden, Deputy Att’y Gen., to Selected United States Att’ys, Investigations 
and Prosecutions in States Authorizing the Medical Use of Marijuana 
(Oct. 19, 2009), http://www.justice.gov/sites/default/files/opa/legacy/2009/
10/19/medical-marijuana.pdf). 
79. Id. (Walters, J., dissenting). 
80. Wyeth v. Levine 555 U.S. 555, 565 (2009) (quoting Medtronic, Inc. v. Lohr, 
518 U.S. 470, 485 (1996)). 
81. Emerald Steel, 230 P.3d at 543 (Walters, J., dissenting). 
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In concluding that the Arizona Medical Marijuana Act (AMMA) 
was not preempted by the CSA, an Arizona trial judge noted that the 
Oregon Supreme Court “stands virtually alone when it suggested that 
almost any State statute that affirmatively authorizes federally con-
flicting conduct is preempted.”82 The Arizona judge argued that AMMA 
actually “further[ed] the CSA’s objectives.”83 AMMA’s strict regulatory 
regime ensured that marijuana was only used for medicinal purposes.84 
Arizona’s other drug abuse prevention laws remained intact.85 AMMA 
also created a registry of persons authorized to grow, sell, and use 
medical marijuana.86 The registry makes people easy targets for federal 
prosecutors, furthering the CSA’s goal of combatting drug trafficking.87 
This Note argues that the Emerald Steel dissent and Arizona judge 
present the stronger arguments. If Congress wished to enforce the CSA 
against medical marijuana growers, sellers, and users it could easily do 
so. But it has not. In fact, since those decisions, the Department of 
Justice has released two more memos reinforcing its position that it will 
not use the CSA to prosecute people who are complying with state 
medical marijuana laws.88 And, at least for the 2015 fiscal year, enforce-
ment of the CSA against medical marijuana users will be nonexistent 
because Congress has deauthorized the use of federal funds for that 
purpose.89 These developments strengthen the argument that Congress 
does not have a clear intention to preempt medical marijuana laws with 
the CSA. 
2.  Federal Law Should Not Preempt a State’s Attempt to Provide 
Employment Rights to Its Medical Marijuana Patients 
A statute that accommodates employees that use medical 
marijuana but includes exemptions to ensure that employers do not 
violate federal law, should not be preempted by the CSA. The statute 
presented in this Note passes the tests for both impossibility and 
obstacle preemption. It will not be impossible for employers to comply 
with this statute because it specifically exempts employers from 
 
82. White Mountain Health Ctr. Inc. v. Cnty. of Maricopa, No. CV 2012-053585, 
2012 WL 6656902, at *8 (Ariz. Sup. Ct. Dec. 3, 2012). 
83. Id. at *6. 
84. Id.  
85. Id. at *7.  
86. Id. at *2.  
87. Id. at *8.  
88. Cole Memo 2011, supra note 31; Cole Memo 2013, supra note 32. 
89. Consolidated and Further Continuing Appropriations Act, 2015, Pub. L. 
No. 113-235, § 538, 128 Stat. 2130, 2217. 
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accommodating medical marijuana users when doing so would cause 
the employer to violate a federal law or lose federal benefits. 
The statute in this Note also does not stand as an obstacle to 
Congress’s objectives in passing the CSA. The statute presented in this 
Note is distinguishable from the statute at issue in Emerald Steel, which 
was unenforceable on obstacle preemption grounds. In Emerald Steel, 
the Oregon Supreme Court held that the provision of Oregon’s medical 
marijuana act that authorized use of medical marijuana was pre-
empted.90 The statute in this Note authorizes employment of medical 
marijuana users. It is already unclear whether Congress intended the 
CSA preempt medical marijuana use. Congressional intent regarding 
employment of medical marijuana users is even less clear and certainly 
not clear enough to supersede the traditional state powers to craft drug 
policy. 
The Emerald Steel decision was an outlier. Almost every case 
regarding termination of medical marijuana users for a positive drug 
test was decided on nonpreemption grounds. The courts in the cases 
decided on nonpreemption grounds made suggestions about what an 
appropriate employee protection statute would look like if the 
legislature were to amend its state’s medical marijuana laws. This 
suggests that those courts would enforce a properly drafted statute that 
protects medical marijuana users. It is unlikely the statute proposed in 
this Note would be preempted. 
B. Even If Not Preempted, State Medical Marijuana Statutes  
Fail to Adequately Protect Employees 
Even if not preempted, courts have consistently ruled that medical 
marijuana laws do not create implied causes of action for employees 
fired after positive drug tests.91 This means that, for the purposes of 
workplace drug tests, licensed medical marijuana users are treated no 
differently than illegal drug users. There is, however, language in both 
 
90. Emerald Steel Fabricators, Inc. v. Bureau of Labor & Indus., 230 P.3d 518, 
536 (Or. 2010). 
91. See, e.g., Casias v. Wal-Mart Stores, Inc., 764 F. Supp. 2d. 914, 924 (W.D. 
Mich. 2011) (“Michigan voters could not have intended to enact private 
employment regulation implicitly, through a negative inference, when the 
rights of employees are never mentioned anywhere else in the statute.”), 
aff’d, 695 F.3d 428 (6th Cir. 2012); Roe v. Teletech Customer Care Mgmt. 
LLC, 257 P.3d 586, 591–92 (Wash. 2011) (“The language of [Washington’s 
medical marijuana law] is unambiguous—it does not regulate the conduct 
of a private employer or protect an employee from being discharged 
because of authorized medical marijuana use.”). Only a few states’ medical 
marijuana statutes directly address the rights of employees. A medical 
marijuana user has yet to challenge an employer in those states, so the 
efficacy of their statutes remains unproven. See infra Part IV for a 
discussion of these states’ statutes. 
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the majority opinions and dissents that shows that courts would honor 
employment rights for medical marijuana users if those rights were 
expressly written into the medical marijuana law. The courts reveal, 
through the opinions and dicta, what it would take for them to rule in 
favor of the employees. This Note applies these lessons in drafting the 
statute presented herein. 
State courts are hesitant to create employment rights for medical 
marijuana users for two primary reasons. First, doing so would violate 
the will of the voters or legislatures that passed the laws. Under the 
courts’ reasoning, if the voters or legislatures had wanted employment 
protections for medical marijuana users, they would have included them 
in the statutes authorizing marijuana use.92 Second, courts fear the 
negative consequences that judicially created employment rights would 
have on employers. For example, forcing employers to violate the 
DFWA. 93 
While court decisions thus far have been unfavorable for employees 
that use medical marijuana, the courts have not foreclosed the 
possibility that the laws could be amended to include employment 
protections. The California Supreme Court said that, although mari-
juana is illegal under federal law, voters “were free to disagree with 
Congress’s assessment of marijuana.”94 It went on to say that a medical 
marijuana law with employment protections should provide notice to 
employers that they must accommodate marijuana use.95 The Washing-
ton Supreme Court suggested that “any statute creating employment 
protections for authorized medical marijuana users might include 
exceptions for certain occupations or permissible levels of impairment 
on the job.”96 
The current case law demonstrates that courts will not find an im-
plied cause of action for wrongful termination in an ambiguous medical 
marijuana statute. Many state statutes could benefit from clearer 
language addressing employment law. Some state statutes only provide 
protection from arrest for authorized medical marijuana use.97 Others 
 
92. Roe, 257 P.3d at 594 (“[T]here is no evidence voters intended 
[Washington’s medical marijuana law] to provide employment protections 
or to prohibit an employer from discharging an employee for medical 
marijuana use.”); Casias, 764 F. Supp. 2d at 926 (“If the voters of Michigan 
meant to enact such sweeping legislation, they had to do so explicitly.”). 
93. Ross v. RagingWire Telecomms., Inc., 33 Cal. Rptr. 3d 803, 811 n.5 (Cal. 
Ct. App. 2005), aff’d, 174 P.3d 200 (Cal. 2008). 
94. Ross, 174 P.3d at 205. 
95. Id. at 208–209. 
96. Roe, 257 P.3d at 593. 
97. Md. Code. Ann., Health–Gen. § 13-3313(a) (West Supp. 2014); Mass 
Gen. Laws Ann. ch. 94C, § 1-4 (West Supp. 2014); Mich. Comp. Laws 
Ann. § 333.26424(a) (West. Supp. 2015); Mont. Code Ann. § 50-46-
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do not prevent arrest but merely provide an affirmative defense to 
prosecution.98 Many also state that nothing in the statute will “require 
any employer to accommodate the medical use of marijuana in any 
work place.”99 Based on how courts have interpreted statutes devoid of 
employment provisions, employees would likely fail if they brought 
wrongful termination suits in these states. These decisions underscore 
the need for legislative action to protect medical marijuana users. 
IV. Some State Medical Marijuana Statutes  
Do Include Employment Provisions 
The state medical marijuana statutes examined in this section have 
provisions explicitly addressing employment. But the employment pro-
visions have yet to be tested in court. The language in these provisions 
provides ideas and guidance to those who wish to amend their states’ 
medical marijuana laws to include employment protections. 
Rhode Island and Connecticut explicitly prohibit employers from 
refusing to employ, or otherwise penalizing, employees solely for their 
status as medical marijuana cardholders.100 Of the laws that address 
employment, these are the least protective. They only protect the fact 
that a person holds a medical marijuana card, not the fact that a person 
may be using marijuana. If an employer in Rhode Island or Connecticut 
fired an employee for a positive drug test the employee would find no 
protection in the state’s law.101 
 
319(2) (2013); N.J. Stat. Ann. § 24:6I-2(e) (West Supp. 2015); N.M. 
Stat. Ann. § 26-2B-4(A) (West 2014); N.Y. Pub. Health Law § 3369 
(McKinney 2014); Vt. Stat. Ann. tit. 18, § 4474b(a) (2013); Wash. 
Rev. Code Ann. § 69.51A.040 (West 2014). 
98. Alaska Stat. § 17.37.030(a) (2012); Colo. Const. art. XVIII, 
§ 14(2)(a)(III); Haw. Rev. Stat. § 329-125(a) (West 2014); Or. Rev. Stat. 
Ann. § 475.319(1) (West Supp. 2014); D.C. Code § 7-1671.08(c) (2012). 
99. Colo. Const. art. XVII, § 14(10)(b). See also Haw. Rev. Stat. § 329-
122(c)(2)(B) (West 2014); Mass. Gen. Laws Ann. ch. 94C, § 1-7(D) 
(West Supp. 2015); Mich. Comp. Laws Ann. § 333.26427(c)(2) (West 
Supp. 2015); N.J. Stat. Ann. § 24-6I-14 (West Supp. 2015); N.M. Stat. 
Ann. § 26-2B-5 (West 2014); Or. Rev. Stat. Ann. § 475.340(2) (West 
2014); Vt. Stat. Ann. tit. 18, § 4474c(a)(1)(B) (West 2014); Wash. 
Rev. Code Ann. § 69.51A.060(4) (West 2014). 
100. 21 R.I. Gen. Laws Ann. § 21-28.6-4(c) (West 2014); Conn. Gen. Stat. 
Ann. § 21a-408p(b)(3) (West 2015). 
101. On November 12, 2014, the ACLU announced that it had filed a complaint 
on behalf of a student who was denied employment because of her status as 
a medical marijuana cardholder in Rhode Island, so that statute may be 
tested soon. ACLU Files Suit Over Medical Marijuana Discrimination,  
ACLU (Nov. 12, 2014), https://www.aclu.org/criminal-law-reform/aclu-files
-suit-over-medical-marijuana-discrimination [https://perma.cc/XVZ9-Q44C].  
In August 2015, a Superior Court judge in Rhode Island denied the defendant 
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Like Rhode Island and Connecticut, Illinois and Maine also prohibit 
employers from refusing to employ, or otherwise penalizing, a person 
based on his or her status as a cardholder, but these states add 
additional protections for employers.102 For example, if accommodating 
a person’s cardholder status would “put the . . . employer . . . in 
violation of federal law or . . . cause it to lose a monetary or licensing-
related benefit under federal law,” the employer is excused from the 
prohibition.103 Furthermore, Illinois explicitly allows employers to 
enforce zero-tolerance or drug-free workplace policies “provided [that] 
the policy is applied in a nondiscriminatory manner.”104 This means that 
employers are free to discipline medical marijuana users for positive 
drug tests as long as they also discipline other drug users in a similar 
manner. 
Arizona, Delaware, and Minnesota have similar employment 
provisions, and these provisions provide the strongest protections for 
employees (relative to other medical marijuana statutes).105 In addition 
to prohibiting employers from discriminating against an employee for 
his or her status as a cardholder, these states also prohibit employers 
from discriminating against employees that test positive for marijuana 
in a drug test.106 These provisions are subject to a few exceptions. First, 
each of the three statutes includes an exception for employers that 
would risk violating federal law or losing federal contracting money if 
they accommodate medical marijuana users.107 Second, if an employee 
uses or is impaired by marijuana while at the workplace they cannot 
seek protection under these statutes.108 
 
employer’s motion to dismiss. Katie Mulvaney, Judge Refuses to Dismiss 
Medical Marijuana User’s Case Against RI Firm, Providence J. (Aug. 11, 
2015), http://www.providencejournal.com/article/20150811/NEWS/150819900  
[http://perma.cc/A463-55YR].  
102. Me. Rev. Stat. Ann. tit. 22, § 2423-E (West 2014); 410 Ill. Comp. 
Stat. Ann. 130/40(a)(1) (West Supp. 2015). 
103. 410 Ill. Comp. Stat. Ann. 130/40(a)(1) (West Supp. 2015). 
104. 410 Ill. Comp. Stat. Ann. 130/50(b)-(c) (West Supp.  2015). 
105. Ariz. Rev. Stat. Ann. § 36-2813(B) (2014); Del. Code Ann. tit. 16, 
§ 4905A(a)(3) (Supp. 2012); Minn. Stat. Ann. § 152.32(3)(c) (West 2014). 
106. Ariz. Rev. Stat. Ann. § 36-2813(B)(2) (2014); Del. Code Ann. tit. 
16, § 4905A(a)(3)(b) (Supp. 2014); Minn. Stat. Ann. § 152.32(3)(c)(2) 
(West Supp. 2015). 
107. Ariz. Rev. Stat. Ann. § 36-2813(B) (2014); Del. Code Ann. tit. 16, 
§ 4905A(a)(3) (Supp. 2014); Minn. Stat. Ann. § 152.32(3)(c) (West 
Supp. 2015). 
108. Ariz. Rev. Stat. Ann. § 36-2813(B)(2) (2014); Del. Code Ann. tit. 
16, § 4905A(a)(3)(b) (Supp. 2014); Minn. Stat. Ann. § 152.32(3)(c)(2) 
(West Supp. 2015). 
Case Western Reserve Law Review·Volume 66·Issue 1·2015 
Protecting Medical Marijuana Users in the Workplace 
226 
New York is unique in that its medical marijuana statute does not 
expressly create employment rights for medical marijuana users, but 
rather it protects employees indirectly by specifying that users are 
considered disabled for the purposes of the state’s disability discrimin-
ation law.109 As with many other medical marijuana law employment 
provisions, there are exceptions allowing employers to enforce policies 
that prohibit employees from working while impaired.110 Employers are 
also exempt if compliance would cause them to violate federal law or 
risk forfeiting a federal contract or funding.111 
A recurring theme throughout the employment discrimination 
provisions in state medical marijuana laws is that employees cannot be 
“impaired” at work.112 Impairment is a broad term. For example, in 
Arizona, symptoms that indicate drug impairment include the 
following: 
[T]he employee’s speech, walking, standing, physical dexterity, 
agility, coordination, actions, movement, demeanor, appearance, 
clothing, odor, irrational or unusual behavior, negligence or 
carelessness in operating equipment, machinery or production or 
manufacturing processes, disregard for the safety of the employee 
or others, involvement in an accident that results in serious 
damage to equipment, machinery or property, disruption of a 
production or manufacturing process, any injury to the employee 
or others or other symptoms causing a reasonable suspicion of the 
use of drugs or alcohol.”113 
Illinois’ impairment definition uses similar language.114 This type of 
“essentially tautological definition provides relatively little practical 
guidance for employers facing difficult decisions concerning the 
 
109. N.Y. Pub. Health Law § 3369(2) (McKinney 2014). 
110. Id. 
111. Id. 
112. See, e.g., N.Y. Pub. Health Law § 3369(2) (McKinney 2014); Ariz. 
Rev. Stat. Ann. § 36-2813(B)(2) (2014); Del. Code Ann. tit. 16, 
§ 4905A(a)(3)(b) (Supp. 2014); Minn. Stat. Ann. § 152.32(3)(c)(2) 
(West Supp. 2015). 
113. Ariz. Rev. Stat. Ann. § 23-493(7) (2015). 
114. Illinois’ definition of impairment includes “specific, articulable symptoms while 
working that decrease or lessen [the employee’s] performance . . . including 
symptoms of the employee’s speech, physical dexterity, agility, coordination, 
demeanor, irrational or unusual behavior.” 410 Ill. Comp. Stat. Ann. 130/50(f) 
(West Supp. 2015). 
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employment of medical marijuana users.”115 Also, while the statute 
names symptoms that are indicative of drug use, some symptoms (like 
appearance and odor) do not necessarily indicate impairment. 
Finally, Nevada’s statute requires that employers “make reasonable 
accommodations” for employees that use medical marijuana as long as 
the accommodations would not (1) “[p]ose a threat of harm or danger 
to persons or property,” (2) “impose an undue hardship on the em-
ployer,” or (3) “[p]rohibit the employee from fulfilling any and all of his 
or her job responsibilities.”116 This is unique in two ways. First, it does 
not include the problematic impairment language included in the other 
states’ medical marijuana statutes. Rather, its narrower language re-
quires employers to show that the employee poses a threat to the work 
place. An employer is justified in firing an employee that poses such a 
threat. Under the statutes that use the term “impairment,” an employer 
may be permitted to fire an employee that simply shows the physical 
signs of impairment (like smell or red eyes) without having to show 
that the employee’s marijuana use poses some threat to the work place. 
Second, Nevada’s statute does not specifically mention federal 
contracting or compliance with federal drug-free workplace laws, 
covering those concerns instead under the “undue hardship” provision. 
The problem with this provision is similar to the problem with the 
impairment provision—its broad language invites litigation. Because 
the statutes do not clarify what an “undue hardship” is, the term will 
have to be clarified in court if litigation ever arises. Clearer language 
will reduce litigation costs by making it clear to employees when their 
employers have the right to fire them. 
V. Statute Recommendation 
The statute presented in this Part addresses the rights of medical 
marijuana cardholders. For the purposes of this statute, as well as many 
states’ medical marijuana statutes, a “cardholder” is a qualifying 
patient or a designated caregiver who has been issued a valid registry 
identification card by the state to possess, use, or cultivate marijuana.117 
Patients are authorized to use marijuana. Caregivers are not authorized 
to use marijuana, but they are authorized to possess it for patients. 
 
115. Michael D. Moberly & Charitie L. Hartsig, Smoke—And Mirrors? 
Employers and the Arizona Medical Marijuana Act, Ariz. Att’y, 
July/Aug. 2011, at 30. 
116. Nev. Rev. Stat Ann. § 453A.800(3) (West 2014). 
117. See, e.g., 21 R.I. Gen. Laws Ann. § 21-28.6-3 (West 2014); Del. Code Ann. 
tit. 16, § 4902A(1) (West Supp. 2014) (both defining a cardholder as a 
qualifying patient or designated caregiver with a valid registry identification 
card). See also Ariz. Rev. Stat. Ann. § 36-2801 (2014) (including nonprofit 
medical marijuana dispensary agent in the definition of “cardholder”). 
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Because patients are the people actually using marijuana, their rights 
are addressed more thoroughly in this statute. 
A. Statute Language 
Based on the recommendations in the case law and the provisions 
in other states’ statutes, I propose that the following language be added 
to medical marijuana statutes: 
§ X. Employment Protections for Medical Marijuana 
Cardholders. 
(a) Unless failure to do so would cause an employer to lose a 
monetary or licensing-related benefit under federal law or 
regulations, an employer shall not discriminate against a person 
in hiring, termination, or any condition of employment, or 
otherwise penalize a person, based upon either of the following: 
(1) That person’s status as a cardholder; or 
(2) A patient’s medical use of marijuana, unless the patient 
ingested or possessed marijuana on the premises of the workplace 
or during work hours, without the written permission of that 
patient’s employer. 
(b) Section (a) of this provision shall not protect a patient whose 
medical use of marijuana either: 
(1) Poses an actual threat of harm or danger to persons or 
property; or 
(2) Makes the patient incapable of performing essential job duties. 
(c) Employers shall be exempt from Section (a) to the extent 
required to comply with state drug testing laws or regulations. 
(d) Employers not exempt from Section (a) shall not be denied 
any benefit for employing the persons identified in Sections (a)(1) 
and (a)(2). 
B. Statute Analysis 
This statutory language combines the best features of existing 
medical marijuana statute employment provisions. It also takes into 
account the lessons from state courts on what makes an appropriate 
statute. It explicitly puts employers on notice that they cannot fire 
employees just for using medical marijuana. And it puts employees on 
notice that they can be fired if their medical marijuana use negatively 
affects their performance or puts the workplace in danger. This section 
discusses the purpose and effect of each part of the statute and how the 
statute improves upon existing law. 
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1. Section (a)—Who and What is Protected by this Statute 
Section (a) of this statute describes who is protected by the statute 
and what activity constitutes employment discrimination against them. 
The statute begins with a clause that exempts employers that would 
violate federal laws like the DWFA if they employed medical marijuana 
users. Most states with employment provisions in their medical 
marijuana statutes have a similar provision. This language protects 
employers and helps the statute withstand a preemption challenge. If 
the law required employers to violate federal law, it would be without 
effect under an impossibility preemption analysis. 
The statute then describes what constitutes employment 
discrimination under this provision. Employers can not consider a 
person’s cardholder status or medical marijuana use when making 
decisions about hiring, termination, or any other condition of employ-
ment (like salary or benefits). “[O]r otherwise penalize a person” is a 
catchall phrase, found in many states’ employment provisions. It 
ensures that patients and caregivers are fully protected from any kind 
of discrimination. 
Medical marijuana cardholders are protected in two specific ways 
by the statute. First, a cardholder’s status is fully protected by the 
statute by Section (a)(1). That means that an employer cannot fire 
someone simply because that person is licensed under a state medical 
marijuana law. Unlike a positive drug test, being a cardholder does not 
necessarily indicate marijuana use. Allowing employers to fire people 
solely for their status as cardholders would be baseless and unfair. 
Licensed patients, growers, sellers, caregivers, and other cardholders all 
benefit from Section (a)(1). 
Section (a)(2) protects an employee’s medical use of marijuana. But 
an employee’s use of marijuana is only protected if two conditions are 
met: (1) the employee is a patient, and (2) the employee does not 
possess or ingest marijuana at the place of employment or during work 
hours without written permission. This section requires an employee to 
be a patient because patients are the only types of cardholders that are 
authorized to use marijuana. 
Section (a)(2) also specifically says that employees cannot “ingest” 
marijuana at work. Although some statutes say that an employee may 
not “use” or “smoke” medical marijuana while at work, those words are 
inadequate. “Use” is too broad of a term. In Coats v. Dish Network, 
LLC,118 the employer argued that the word “use” included situations in 
which the employee, Brandon Coats, consumed marijuana off-duty and 
off-premises.119 The employer cited Coats’ opening brief, which stated 
 
118.  350 P.3d 849 (Colo. 2015). 
119. Answer Brief at 6, Coats v. Dish Network, LLC, 350 P.3d 849 (Colo. 2015) 
(No. 11-CV-1464).  
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that Coats’s medical marijuana use “decreased painful muscle spasms, 
allowing Coats to work.”120 Because “he was using [medical marijuana] 
to control his symptoms at work, he was ‘medically using’ marijuana 
on-duty, on-premises.”121 If a court accepted that argument, an 
employee would not be protected by a statute that barred “use” of 
marijuana at work. “Smoke” has a different problem—it is too narrow 
of a word. Marijuana can be vaporized, eaten, used as a tincture, or 
ingested in other ways. Thus, this statute uses the word “ingest,” which 
the Merriam-Webster dictionary defines as “to take (something, such 
as food) into your body.”122 This word is broad enough (unlike the word 
“smoke”) to encompass all forms of marijuana consumption, yet narrow 
enough (unlike the word “use”) to require that the employee actually 
take the marijuana in the work place or during work hours. 
Provisions allowing employers to bar use of marijuana in the 
workplace are standard in state medical marijuana laws. This statute 
adds special language that allows employees to use marijuana with the 
employer’s permission. Requiring the employee to obtain written 
permission protects both employers and employees by creating 
documentation of any permission the employee receives. If the employee 
is later terminated for using or possessing marijuana at work, the 
documentation, or lack thereof, could be dispositive for the case. 
2. Section (b)—When Medical Marijuana Use Is Not Protected by this 
Statute 
Section (b) addresses employers’ interests in workplace safety and 
employee performance. It allows employers to achieve the same goals 
as drug testing—keeping dangerous and incapable employees out of the 
workplace. But it also protects medical marijuana users from being fired 
when their marijuana use has no negative effect on their job. Although 
many states exempt employees that are “impaired” at work from pro-
tection, this statute uses narrower language. The narrower language 
allows the statute to reduce the risk that an employee will be fired for 
an arbitrary reason while still accomplishing the ultimate purpose of 
impairment language—keeping negative effects of drug use out of the 
workplace. 
Section (b)(1) treats medical use of marijuana like prescription drug 
use. Even though their drugs are legal under both state and federal law, 
prescription drug users can face discipline if their drug use threatens 
the workplace. For example, railroad employees can only use 
 
120. Id. (quoting Opening Brief at 51, Coats v. Dish Network, LLC, 350 P.3d 849 
(Colo. 2015) (No. 11-CV-1464)).  
121. Id. 
122. Dictionary—Ingest, Merriam-Webster, http://www.merriam-webster.com/ 
dictionary/ingest [http://perma.cc/CGP5-C2Q4] (last visited Oct. 1, 2015). 
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prescription drugs if they can do so in a way that is “consistent with 
the safe performance” of their employment duties.123 Similarly, the ADA 
permits employers to fire employees whose prescription drug use poses 
a “direct threat to the health or safety of other individuals in the 
workplace.”124 Section (b)(2) precludes employees from using marijuana 
use as an excuse for failing to perform up to standards. Its language is 
also similar to that of the ADA: The ADA requires a claimant to be 
able to perform “essential functions of the employment position that 
such individual holds or desires.”125 
While employers use generalizations about marijuana to justify 
workplace drug policies, marijuana’s effects vary widely based on 
factors such as the user’s tolerance, dosage, type of marijuana used, and 
method of ingestion.126 Sections (b)(1) and (b)(2) protect medical mari-
juana users from these generalizations by ensuring them the right to an 
individualized assessment.127 
An employer could not cite to Section (b) as a reason to not hire 
an applicant. Before employment, a medical marijuana user has yet to 
threaten the workplace or perform poorly. In many states, employers 
can fire medical marijuana users because the employers fear the effects 
that marijuana might have on the user. This statute requires that the 
marijuana actually have an effect. Mere knowledge that an employee 
uses medical marijuana is not a sufficient reason for termination. 
3. Section (c)—Respecting State Drug Testing Laws 
Section (c) ensures that this provision does not displace state drug 
testing laws. Like the federal government, states also mandate drug 
testing for certain employees. For example, Connecticut requires drug 
testing of school bus drivers and other employees that serve in “high-
risk or safety-sensitive” occupations.128 If a state adopts the statute 
proposed in this Note, then it should amend Section (c) to expressly 
state which state drug testing laws supersede this statute. This would 
put employers and employees on notice about how to comply with this 
statute. 
Section (c) allows employers to violate Section (a) (which prohibits 
employers from taking adverse action against medical marijuana users) 
when employers must comply with state drug testing laws. If it did not, 
 
123. 49 C.F.R. § 219.103 (2014). 
124. 42 U.S.C. § 12113(b) (2012). 
125. 42 U.S.C. § 12111(8) (2012). 
126. Report, supra note 15, at 61–63. 
127. See Hickox, supra note 41, at 1045 (“Under the ADA, the employer’s 
proof that an individual poses a ‘direct threat’ must be based on an 
‘individualized assessment of the individual’s present ability to safely 
perform the essential functions of the job.’”). 
128. Conn. Gen. Stat. Ann. § 31-51x (West Supp. 2015). 
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then employers face an impossible choice when their employees used 
medical marijuana—fire the employee and risk violating this statute or 
adhere to this statute and violate state law. 
4. Section (d)—Additional Protection for Employers 
Section (d) protects employers from medical marijuana related 
discrimination. It ensures that compliance with this statute, which 
restricts the situations in which an employer may fire or otherwise dis-
cipline medical marijuana users, will not cause the employer any 
detriment. States and insurance companies may attempt to encourage 
zero-tolerance workplace drug policies by offering benefits to employers 
that enforce them. With Section (d), an employer could not be denied 
any benefit for refusing to take adverse action against an employee 
(assuming the employer adhered to the other conditions attached to the 
benefits). 
Conclusion 
The terminated medical marijuana users mentioned at the 
beginning of this Note—Gary Ross, Joseph Casias, Brandon Coats—
could have vindicated their rights in court if their states’ medical 
marijuana laws had contained the statutory language proposed in this 
Note. Unfortunately many states’ medical marijuana laws still lack 
employment provisions. This Note recommends that states adopt the 
proposed statutory language into their medical marijuana laws. 
The CSA’s classification of marijuana as a Schedule I substance has 
been attacked since its inception. The National Commission on 
Marihuana and Drug Abuse, whose creation was mandated by the CSA, 
was the first to disagree with the classification. In 1972, the Commission 
found that “[m]arihuana’s relative potential for harm to the vast 
majority of individual users and its actual impact on society does not 
justify a social policy designed to seek out and firmly punish those who 
use it.”129 Since then, even more research has shown that marijuana 
should not be classified as a Schedule I substance. 
Almost twenty years have passed since California enacted the 
nation’s first medical marijuana law.130 In that time, twenty-two other 
states and Washington, D.C. have also enacted medical marijuana 
laws.131 Enforcement of the CSA against medical marijuana users is 
weak. The Department of Justice has released several memos stating  
129. Report, supra note 15, at 163. 
130. California voters passed the state’s medical marijuana law in 1996. State 
Medical Marijuana Laws, Nat’l Conf. of State Legislatures (Aug. 
11, 2015), http://www.ncsl.org/research/health/state-medical-marijuana
-laws.aspx [http://perma.cc/SQQ4-ACU3]. 
131. Id. 
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that it will not target state law–compliant medical marijuana users. 
Also, Congress’s spending bill for the 2015 fiscal year prohibits the 
Department of Justice from interfering with state medical marijuana 
laws.132 Non-enforcement of the CSA lends strength to the argument 
that the CSA would not preempt a state statute protecting medical 
marijuana users’ employment rights. Also, unlike the statute preempted 
in Emerald Steel, this statute would not be preempted because it only 
authorizes employment of medical marijuana users, not use of 
marijuana.133 
The conflict between state and federal marijuana laws causes 
confusion for employers, who are unsure whether state medical 
marijuana laws supersede their power to enforce drug-free workplace 
policies against employees.134 Courts consistently rule in favor of 
employers when medical marijuana users challenge drug-free workplace 
policies, but they have not foreclosed the possibility that state medical 
marijuana laws could protect employees. Nevertheless, without explicit 
statutory guidance, the courts will not recognize these rights. A state’s 
medical marijuana statute should clearly address the scope of accommo-
dation that employers must provide to medical marijuana users. 
With this provision in their states’ medical marijuana laws, courts 
could not dismiss an employee’s complaint for failure to state a claim 
on the grounds that the language of the medical marijuana law “does 
not regulate the conduct of a private employer or protect an employee 
from being discharged because of authorized medical marijuana use.”135 
This provision puts both employers and employees on notice about the 
scope of an employer’s duty to accommodate medical marijuana use. 
The statute in this Note protects medical marijuana users but not 
recreational marijuana users (even if they are using the drug in 
compliance with state law). The reason for this distinction is that 
medical users rely on marijuana to alleviate symptoms of disabilities. 
Current law forces medical users to choose between pain relief and 
 
132. Consolidated and Further Continuing Appropriations Act, 2015, Pub. L. 
No. 113-235, § 538, 128 Stat. 2130, 2217 (2014).  
133. Emerald Steel Fabricators, Inc. v. Bureau of Labor & Indus., 230 P.3d 
518 (Or. 2010). For a discussion of the Emerald Steel obstacle preemption 
analysis, see supra Part III.A.i. 
134. “[M]any employers lack a clear understanding of how to treat medical 
marijuana users.” Hickox, supra note 41, at 1004 (2011) (surveying employers 
about why they drug test and the consequences for positive drug tests). 
135. Roe v. Teletech Customer Care Mgmt. LLC, 257 P.3d 586, 591–92 (Wash. 
2011). See also Ross v. RagingWire Telecomms., Inc., 174 P.3d 200, 207 (Cal. 
2008) (holding that “given the controversy that would inevitably have attended 
a legislative proposal to require employers to accommodate marijuana use, we 
do not believe that [California’s medical marijuana law] can reasonably be 
understood as adopting such a requirement silently and without debate.”). 
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employment. Recreational users, on the other hand, do not have to 
make that choice. The statute in this Note does as much as possible to 
eliminate the risk that medical marijuana users will face that choice. 
States have finally given people suffering from illness and disability 
access to a drug that can help them feel better—marijuana. But some 
risk their jobs if they use it, even if that use is off-site and does not 
affect the workplace. The ideas in this Note could be used to expand 
the rights of medical marijuana users in the fields of housing, education, 
parenting, and other areas. The courts have made it clear that state 
medical marijuana laws need to provide these rights explicitly. 
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